Search Results

dependent pathways to regulate pancreatic β cell function GPCR Binders, Drugs, and more GPC-100, a novel CXCR4

Re-routing GPR56 signaling using Gα12/13 G protein chimeras GPCRs in Oncology and Immunology Chemokine Cxcl1-Cxcl2

agonists of angiotensin II type 2 receptor may prevent colorectal cancer Distinct Activation Mechanisms of CXCR4

GPCR Activation and Signaling Phosphorylation barcodes direct biased chemokine signaling at CXCR3.

a theranostic agent for the type 2 vasopressin receptor Small-Molecule Fluorescent Ligands for the CXCR4

for TSH action with disease implications GPCRs in Oncology and Immunology LPA1-mediated inhibition of CXCR4

N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5 Chemokine Cxcl1-Cxcl2

partner, GPCR Therapeutics, for partnering with Bridge Biotherapeutics to pioneer IPF treatment with CXCR4

from Cryptostegia grandiflora against Candida auris FKBP12 Development and therapeutic perspectives of CXCR4

+ chemokine ligands show G protein bias over β-arrestin recruitment and receptor internalization in CXCR1

GPCR Activation and Signaling The dual-function chemokine receptor CCR2 drives migration and chemokine